Actinium Pharmaceuticals (ATNM) Invested Capital (2019 - 2026)
Actinium Pharmaceuticals (ATNM) posted quarterly Invested Capital of $25000.0 for Q2 2024, down 10.71% quarter-over-quarter from $28000.0 in Q1 2024.
Actinium Pharmaceuticals (ATNM) Invested Capital (2019 - 2026) Analysis & Trends
Actinium Pharmaceuticals (ATNM) has reported Invested Capital for 3 consecutive years, with $25000.0 the latest figure, recorded in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Actinium Pharmaceuticals | 35.01 Mn | 35.01 Mn | - | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 28,000.00 |
| Sep 30, 2023 | 30,000.00 |
| Mar 31, 2019 | 26,254.00 |